NEW YORK, January 3, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Debbie Warner as a Vice President in the Commercial Planning group. In this role, she will lead Kantar Health’s Oncology Commercial Strategies team.
The Oncology Commercial Strategies team focuses on providing cutting-edge information and analysis regarding the dynamic U.S. oncology market landscape and the influence of multiple stakeholders such as community and institutional providers, payers, patients and manufacturers. An analysis of each of these stakeholders and key trends in coverage policy and reimbursement are included in Oncology Market Access U.S., a web-resident source of information that helps pharmaceutical marketing and sales professionals successfully commercialize cancer drugs in an increasingly scrutinized and regulated oncology marketplace. Ms. Warner’s team also works directly with clients on custom engagements to optimize their oncology commercialization strategies for the dynamic healthcare landscape.
Ms. Warner has more than 20 years of experience in the pharmaceutical industry with Merck, Astra Merck and AstraZeneca, including positions in field sales, national accounts, brand management, medical affairs and managed markets strategy. Most recently she was the Managed Markets Brand Director, Specialty Care Oncology Growth Brands, where she leveraged her commercial and clinical experience and payer perspectives to launch and grow brands with broad market access.
“Debbie’s commercial development experience in the pharmaceutical industry will give our clients the benefit of insightful analysis and actionable recommendations as they compete in an increasingly challenging oncology market,” says Patricia A. Ensor, R.Ph., Senior Vice President of Kantar Health. “Her background enhances Kantar Health’s vast global oncology offer, which combines custom consulting and multiclient subscriptions.”
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at email@example.com or +1-484-442-1431.